
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1095 | 1079 | 1114 | 1320 | 1594 | 1843 |
Fund Return | 9.52% | 7.89% | 11.36% | 9.7% | 9.77% | 6.3% |
Place in category | 35 | 47 | 71 | 40 | 40 | 15 |
% in Category | 49 | 65 | 74 | 56 | 53 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC Canadian Dividend Fund Series I | 21.06B | 2.55 | 8.32 | 8.58 | ||
RBC Canadian Div Fund Series D CAD | 21.06B | 2.46 | 7.75 | 7.98 | ||
RBC Canadian Div Fund Series F CAD | 21.06B | 2.51 | 8.05 | 8.28 | ||
RBC Sel Gr Port Sr F CAD | 16.41B | 2.66 | 8.02 | 7.31 | ||
RBC Sel Gr Port Sr T5 | 16.41B | 2.49 | 6.94 | 6.22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC European Mid-Cap Equity Fund D | 1.66B | 6.47 | 1.44 | - | ||
Investors European Mid Cap Equity C | 1.1B | 6.56 | 5.08 | 4.18 | ||
Investors European Mid Cap Equity B | 1.1B | 6.65 | 5.32 | 4.39 | ||
Investors European Mid Cap Eq J NL | 1.1B | 6.70 | 5.61 | 4.67 | ||
Investors European Mid Cap Equity U | 1.1B | 6.92 | 6.96 | 6.01 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
EssilorLuxottica | FR0000121667 | 4.92 | 249.40 | +6.63% | |
Novo Nordisk B | DK0062498333 | 4.85 | 427.4 | +5.79% | |
UBS Group | CH0244767585 | 3.55 | 23.61 | +7.66% | |
Roche Holding Participation | CH0012032048 | 3.51 | 245.70 | +4.38% | |
ASML Holding | NL0010273215 | 3.50 | 591.70 | +6.75% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review